Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
23.56
-0.09 (-0.38%)
At close: Apr 28, 2026, 4:00 PM EDT
23.82
+0.26 (1.10%)
Pre-market: Apr 29, 2026, 8:14 AM EDT
Legend Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -296.8 | -177 | -518.3 | -446.35 | -403.58 | Upgrade
|
| Depreciation & Amortization | 28.9 | 21.4 | 18.5 | 18.39 | 12.54 | Upgrade
|
| Other Amortization | - | - | - | - | 1.38 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.48 | 0.97 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 4.4 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -0.7 | -0.59 | - | Upgrade
|
| Stock-Based Compensation | 64.6 | 68.9 | 47.7 | 34.34 | 20.16 | Upgrade
|
| Other Operating Activities | 196.2 | -80.1 | 132.2 | 5.24 | 8.15 | Upgrade
|
| Change in Accounts Receivable | -5.7 | 93.8 | -99 | 50.32 | 24.59 | Upgrade
|
| Change in Inventory | -4.5 | -17.2 | -12.7 | -13.89 | 0.05 | Upgrade
|
| Change in Accounts Payable | 44.4 | 14.1 | -50.2 | 72.45 | 1.81 | Upgrade
|
| Change in Unearned Revenue | -40 | -49.7 | 100 | 6.18 | 0.08 | Upgrade
|
| Change in Other Net Operating Assets | -87.3 | -22.6 | -10.8 | 72.16 | 135.39 | Upgrade
|
| Operating Cash Flow | -100.2 | -144 | -393.3 | -201.28 | -198.47 | Upgrade
|
| Capital Expenditures | -28.6 | -14.1 | -20.1 | -20.93 | -42.2 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -2.6 | -1.35 | -3.21 | Upgrade
|
| Investment in Securities | 777 | -784.6 | 204.6 | -41.36 | -147.88 | Upgrade
|
| Other Investing Activities | -38.8 | -51.9 | -89 | -13.45 | -1.71 | Upgrade
|
| Investing Cash Flow | 709.6 | -850.6 | 92.9 | -77.09 | -194.98 | Upgrade
|
| Long-Term Debt Repaid | -3.6 | -4 | -3.8 | -2.6 | -1.42 | Upgrade
|
| Total Debt Repaid | -3.6 | -4 | -3.8 | -2.6 | -1.42 | Upgrade
|
| Net Debt Issued (Repaid) | -3.6 | -4 | -3.8 | -2.6 | -1.42 | Upgrade
|
| Issuance of Common Stock | 3.3 | 9.7 | 795.2 | 380.57 | 628.08 | Upgrade
|
| Financing Cash Flow | -0.3 | 5.7 | 791.4 | 377.98 | 626.66 | Upgrade
|
| Foreign Exchange Rate Adjustments | 6.1 | -2.1 | 0.7 | -2.51 | 0.03 | Upgrade
|
| Net Cash Flow | 615.2 | -991 | 491.7 | 97.09 | 233.25 | Upgrade
|
| Free Cash Flow | -128.8 | -158.1 | -413.4 | -222.21 | -240.66 | Upgrade
|
| Free Cash Flow Margin | -12.52% | -25.20% | -145.00% | -189.91% | -349.67% | Upgrade
|
| Free Cash Flow Per Share | -0.70 | -0.86 | -2.35 | -1.40 | -1.71 | Upgrade
|
| Cash Interest Paid | 3.5 | 1.8 | 1.4 | 0.53 | 0.14 | Upgrade
|
| Cash Income Tax Paid | 18.4 | 1.6 | -0.3 | -3.71 | -0.56 | Upgrade
|
| Levered Free Cash Flow | -133.99 | -40.55 | -496.78 | -202.66 | -122.84 | Upgrade
|
| Unlevered Free Cash Flow | -120.61 | -27.05 | -483.16 | -195.91 | -122.28 | Upgrade
|
| Change in Working Capital | -93.1 | 18.4 | -72.7 | 187.21 | 161.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.